New Ray Medicine International Holding Ltd. (HK:6108) has released an update.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
New Ray Medicine International Holding Ltd. has announced that out of the HK$330 million raised in their Rights Issue, approximately HK$39.6 million remains unutilized. The company has allocated HK$17.3 million for acquiring a stake in China Nvwa Pharmaceutical Group and plans to use the rest for general working capital, aiming to bolster their domestic and overseas pharmaceutical business in the PRC.
For further insights into HK:6108 stock, check out TipRanks’ Stock Analysis page.